Evidence map›Paper›PMID 35042773›Full record

ArticleImmunoHorizons2022

An Unexpected Role for Cell Density Rather than IgM in Cell-Surface Display of the Fc Receptor for IgM on Human Lymphocytes.

Cassandra R Woolley, Nicholas C Brinkman, Elizabeth D Cash, Swapna K Chandran, Thomas C Mitchell

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cassandra R WoolleyDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY.ORCID 0000-0003-2752-1351
Nicholas C BrinkmanDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY.
Elizabeth D CashDepartment of Otolaryngology Head and Neck Surgery & Communicative Disorders, University of Louisville School of Medicine, Louisville, KY; and.ORCID 0000-0003-4148-6927
Swapna K ChandranDepartment of Otolaryngology Head and Neck Surgery & Communicative Disorders, University of Louisville School of Medicine, Louisville, KY; and.
Thomas C MitchellDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY; thomas.mitchell@louisville.edu.ORCID 0000-0002-6493-2232
University of Louisville · US

Funding

Mechanisms of successful vaccine adjuvantsR01AI127970 · NIAID · UNIVERSITY OF LOUISVILLE · PI MITCHELL, THOMAS C. · 2017 to 2021
$1.9M
NIAID NIH HHS R01 AI127970
6 · The paper itself

Abstract

The Fc receptor for IgM, FcMR, is unusual in that it is preferentially expressed by cells of the adaptive immune system. It is, moreover, the only constitutively expressed Fc receptor on human T cells. Efforts to decipher the normal functions of FcMR have been complicated by species-specific expression patterns in lymphocytes from mice (B cells) versus humans (B, NK, and T cells). In human cells, FcMR cell-surface expression has been reported to be low at baseline ex vivo, with one suggested contribution being ligand-induced internalization by serum IgM. Indeed, preincubation overnight in IgM-free culture medium is recommended for studies of FcMR because surface display is increased under these conditions. We investigated FcMR display on human lymphocytes in PBMCs and found that, surprisingly, cell-surface FcMR was unaffected by IgM abundance and was instead downregulated in high-cell density cultures by a yet undefined mechanism. We further found that ex vivo processing of whole blood decreased surface FcMR, supporting the idea that FcMR expression is likely to be greater on circulating lymphocytes than previously appreciated. Collectively, these findings prompt new predictions of where and when FcMR might be available for functional interactions in vivo.

Indexed as

B-LymphocytesCell CountHumansImmunoglobulin MLeukocytes, MononuclearLymphopoiesisMembrane ProteinsReceptors, FcT-LymphocytesImmunoglobulin MMembrane ProteinsReceptors, Fc

Identifiers

PMID35042773
PMCPMC9535691
OpenAlexW4206165630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.